Overland Pharmaceuticals, supported by Hillhouse Capital, is constructing a fully integrated biopharmaceutical company with the aim of providing groundbreaking drugs to underserved patients in Asia and other parts of the globe. By utilizing our resources, worldwide connections, and local knowledge throughout the biopharmaceutical sector in Asia, Overland is developing a collection of distinctive therapeutic candidates in carefully chosen therapeutic areas. Through strategically formed partnerships, Overland concentrates on inventive therapeutic programs and state-of-the-art technology platforms to deliver optimal value to all stakeholders, ultimately aiming for the highest benefit.